Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference

The orally active dual OX1R and OX2R antagonist, almorexant, targets the orexin system for the treatment of primary insomnia. This clinical trial assessed the effect of almorexant on sleep maintenance and other sleep endpoints, and its safety and tolerability in adults.

http://ift.tt/2rehQm6